CareDx, Inc. (CDNA) — Stock Score Summary

CareDx, Inc. (CDNA) has a MoatMap StockRank of 86/100 based on Quality (62/100), Value (33/100), and Momentum (76/100) factor scores. The current signal is STRONG BUY. CareDx is a transplant diagnostics provider with a solid niche, but it is completely disconnected from our 18-month macro themes and faces ongoing regulatory and reimbursement uncertainties.

CareDx, Inc. is a leading precision medicine company focused on developing and commercializing diagnostic solutions for transplant patients, including proprietary molecular diagnostic tests and digital health software for monitoring organ health and rejection. The company's competitive moat is built upon its innovative, clinically validated tests like AlloSure and AlloMap, strong intellectual property, and deep integration with transplant centers globally. CareDx holds a leading position in a critical and specialized healthcare niche with high barriers to entry.

Key Financial Metrics

Price$22.20
Market Cap$1.2B
P/E (Forward)20.39
Price/Book3.78
Return on Equity-2.4%
Return on Invested Capital-7.8%
Debt/Equity7.81
Gross Margin68.9%
Operating Margin1.5%
Revenue Growth39.0%
Free Cash Flow$70M

CareDx, Inc. operates in the Diagnostics & Research industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is CareDx, Inc.’s (CDNA) StockRank?
MoatMap’s StockRank for CareDx, Inc. (CDNA) is 86/100, with a Strong Buy signal. It is a composite of Quality (62), Value (33), and Momentum (76) factor ranks across MoatMap’s 19,000+ stock universe.
Does CareDx, Inc. have an economic moat?
CareDx, Inc. (CDNA) has a Quality factor score of 62/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is CareDx, Inc. a buy, hold, or sell?
MoatMap’s current signal for CareDx, Inc. (CDNA) is Strong Buy, based on a StockRank of 86/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is CareDx, Inc. in?
CareDx, Inc. (CDNA) operates in the Healthcare sector, specifically the Diagnostics & Research industry (United States).
Browse all ranked stocksCDNA deep dive reportAI ChampionsHow we score stocksSense-check another stock